Company Filing History:
Years Active: 2020-2023
Title: Ian Gurrell: Innovator in Antibody Research
Introduction
Ian Gurrell is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of antibody research, particularly in the development of anti-PAR2 antibodies. With a total of 2 patents to his name, Gurrell's work has the potential to impact various therapeutic applications.
Latest Patents
Gurrell's latest patents include "Nucleic acids encoding anti-PAR2 antibodies and uses thereof." This patent provides antibodies and antigen-binding fragments capable of binding PAR2. In some embodiments, the anti-PAR2 antibodies or antigen-binding fragments bind PAR2 in a pH-dependent manner. The disclosure further provides methods for making and using these antibodies and antigen-binding fragments. Another significant patent is titled "Anti-PAR2 antibodies and uses thereof," which shares similar features and applications as the previous patent.
Career Highlights
Ian Gurrell is currently associated with Medimmune Limited, where he continues to advance his research in antibody development. His work is crucial in understanding the mechanisms of PAR2 and its implications in various diseases.
Collaborations
Gurrell collaborates with esteemed colleagues, including Claire Louise Dobson and Richard Williams, to enhance the scope and impact of his research.
Conclusion
Ian Gurrell's innovative work in the field of antibody research, particularly with anti-PAR2 antibodies, showcases his commitment to advancing medical science. His contributions are expected to lead to significant advancements in therapeutic applications.